Pennsylvania SB461 mandates health insurance coverage for Lyme disease and related tick-borne illnesses, including diagnostic testing and treatment.

Pennsylvania SB461, the Lyme Disease and Related Tick-Borne Illness Diagnosis and Treatment Act, requires health insurance policies to cover diagnostic testing and treatment for Lyme disease and related tick-borne illnesses. The act aims to promote education and awareness among health care practitioners, reduce the incidence of these diseases, and improve public awareness and prevention practices. It mandates coverage for diagnostic testing, tick testing, and prescribed treatments, subject to copayments, deductibles, and coinsurance.

Pennsylvania SB461 mandates health insurance coverage for Lyme disease and related tick-borne illnesses, including diagnostic testing and treatment.

Pennsylvania SB461, the Lyme Disease and Related Tick-Borne Illness Diagnosis and Treatment Act, requires health insurance policies to cover diagnostic testing and treatment for Lyme disease and related tick-borne illnesses. The act aims to promote education and awareness among health care practitioners, reduce the incidence of these diseases, and improve public awareness and prevention practices. It mandates coverage for diagnostic testing, tick testing, and prescribed treatments, subject to copayments, deductibles, and coinsurance.